Houston biotech firm Coya Therapeutics files for IPO

About two years after its launch, Coya Therapeutics is going public. The Houston firm specializes in cell therapies targeting neurodegenerative diseases.

North Peoria restaurant, retail plaza lands four key tenants

FDA rejects Malvern pharma firm’s non-opioid pain killer for a second time

Exclusive: Ohio-based engineering firm opens first Florida office in Tampa

Above the Fold: Josh Wamsley, founder of Mazunte Taqueria, on the Cincinnati Business Courier podcast

Pittsburgh Penguins announce executive promotions

Downtown San Jose hotel and condo development secures dual Marriott brands

Executive Insights: Mike Huseman CEO of Huseman Group

A tiny Waltham biotech just scored a $509M+ deal with Boehringer Ingelheim

Houston biotech firm Coya Therapeutics files for IPO

Previous 2 Missouri hospitals recognized in national ranking

Next Inno Fire Awards honoree: SweetBio and co-founder Kayla Rodriguez Graff

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Melt Bar and Grilled owner pauses expansion, considers new restaurant concept

Local credit union leaders, NCUA board member share steps taken to avoid financial crisis

Why Charlotte Avenue caught this hospitality veteran’s eye for multiple investments

New offers, digital potential keep Wendy’s optimistic

Wingo gets new partner for Triangle Tweener Fund

Prefix Coffee takes over two Made in KC leases

MENU

FirstStar Group

More Stories

Catalina’s ‘big brain’ goes to work for emerging brands

Previous 2 Missouri hospitals recognized in national ranking

Next Inno Fire Awards honoree: SweetBio and co-founder Kayla Rodriguez Graff

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories